We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $3.01B
1-Year Est. Return 119.46%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+119.46%
3 Year Est. Return
+340.9%
5 Year Est. Return
+347.01%
10 Year Est. Return
+3,143.27%
AUM
$2.72B
AUM Growth
-$309M
Cap. Flow
+$81.1M
Cap. Flow %
2.98%
Top 10 Hldgs %
40.44%
Holding
175
New
22
Increased
46
Reduced
28
Closed
23

Top Buys

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$29.6M
2
MLYS icon
Mineralys Therapeutics
MLYS
+$22.9M
3
CWH icon
Camping World
CWH
+$22.7M
4
VSTM icon
Verastem
VSTM
+$19.3M
5
TBBK icon
The Bancorp
TBBK
+$18.5M

Top Sells

Rank Stock Value
1
TNGX icon
Tango Therapeutics
TNGX
+$32.3M
2
EB
Eventbrite
EB
+$30.5M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$30.2M
4
RAPT
RAPT Therapeutics
RAPT
+$25.5M
5
GMED icon
Globus Medical
GMED
+$19.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.58%
2 Healthcare 36%
3 Consumer Discretionary 9.68%
4 Financials 3.92%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLDB icon
76
Solid Biosciences
SLDB
$1.05B
$8.39M 0.31%
1,165,078
-438,258
-27% -$2.82M
TLSI icon
77
TriSalus Life Sciences
TLSI
$297M
$8.28M 0.3%
2,070,827
– –
CRMT icon
78
America's Car Mart
CRMT
$20.6M
$8.21M 0.3%
644,686
– –
VMD icon
79
Viemed Healthcare
VMD
$336M
$8.14M 0.3%
883,783
-48,662
-5% -$405K
RH icon
80
RH
RH
$2.83B
$8.08M 0.3%
57,791
+20,000
+53% +$3.64M
IRD
81
Opus Genetics
IRD
$307M
$7.65M 0.28%
1,681,330
-3,100,000
-65% -$10.7M
KRRO icon
82
Korro Bio
KRRO
$190M
$7.47M 0.28%
660,036
+60,036
+10% +$661K
AMLX icon
83
Amylyx Pharmaceuticals
AMLX
$3.87B
$7.45M 0.27%
535,684
-300,000
-36% -$4.22M
DMRA
84
Damora Therapeutics
DMRA
$1.79B
$7.2M 0.27%
+278,000
New +$7.15M
RH icon
85
CALL
RH
RH
$2.83B
$6.99M 0.26%
50,000
– –
LXEO icon
86
Lexeo Therapeutics
LXEO
$399M
$6.89M 0.25%
1,200,000
+200,000
+20% +$1.42M
VENU
87
Venu Holding Corp
VENU
$114M
$6.77M 0.25%
+2,046,705
New +$11.8M
TBBK icon
88
CALL
The Bancorp
TBBK
$2.68B
$6.76M 0.25%
+125,800
New +$7.53M
CDXS icon
89
Codexis
CDXS
$174M
$6.72M 0.25%
4,123,613
+133,444
+3% +$190K
DHX icon
90
DHI Group
DHX
$176M
$6.67M 0.25%
2,374,027
– –
UNCY icon
91
Unicycive Therapeutics
UNCY
$147M
$6.18M 0.23%
939,202
– –
GUTS icon
92
Fractyl Health
GUTS
$105M
$6.12M 0.23%
13,364,519
+2,518,079
+23% +$2.32M
ALEC icon
93
Alector
ALEC
$261M
$6.05M 0.22%
+2,815,983
New +$5.66M
HAIN icon
94
Hain Celestial
HAIN
$66.1M
$5.95M 0.22%
8,528,789
+2,000,000
+31% +$1.86M
DNTH icon
95
Dianthus Therapeutics
DNTH
$5.92B
$5.65M 0.21%
67,282
-307,718
-82% -$17.8M
NSPR icon
96
InspireMD
NSPR
$39.8M
$5.5M 0.2%
3,376,484
– –
KOS icon
97
Kosmos Energy
KOS
$1.64B
$5.13M 0.19%
1,844,194
-500,000
-21% -$940K
COCH icon
98
Envoy Medical
COCH
$53.3M
$5.09M 0.19%
+7,650,000
New +$5.22M
ALTG icon
99
Alta Equipment Group
ALTG
$192M
$5.02M 0.18%
934,774
– –
DRIO icon
100
DarioHealth
DRIO
$66.3M
$4.9M 0.18%
610,690
+47,458
+8% +$495K
2 3
4
5 6

Similar funds

MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $3.02B AUM 91.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Nantahala Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Nantahala Capital Management held 175 positions worth $2.72B, down 10% from $3.02B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Nantahala Capital Management's Q1 2026 filing shows 22 new, 46 increased, 28 reduced and 23 closed positions. Its largest new stake was AgomAb Therapeutics NV: 1,200,000 shares worth $12.9M. The largest sale was Tango Therapeutics, an estimated $32.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nantahala Capital Management's largest Q1 2026 buy was AgomAb Therapeutics NV: 1,200,000 shares worth $12.9M.
  • Nantahala Capital Management added most to Peloton Interactive in Q1 2026, an estimated $29.6M increase.
  • Nantahala Capital Management's biggest Q1 2026 reduction was Tango Therapeutics, cutting an estimated $32.3M.
  • Nantahala Capital Management fully exited Eventbrite in Q1 2026, selling an estimated $30.5M.
  • Nantahala Capital Management's ten largest holdings make up 40% of its $2.72B portfolio in Q1 2026.
  • Nantahala Capital Management opened 22 new positions and closed 23 in Q1 2026.
  • Nantahala Capital Management's portfolio value fell 10% quarter-over-quarter to $2.72B.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.